These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 580582)
1. [Studies on the disposition of meproscillarin in rat and dog (author's transl)]. Weymann J; Schenk G; Kesselring K Arzneimittelforschung; 1978; 28(3a):520-6. PubMed ID: 580582 [TBL] [Abstract][Full Text] [Related]
2. [Metabolism of meproscillarin in man (author's transl)]. Rietbrock N Arzneimittelforschung; 1978; 28(3a):540-5. PubMed ID: 580585 [TBL] [Abstract][Full Text] [Related]
3. [On the possible meproscillarin accumulation in patients with impaired renal function (author's transl)]. Twittenhoff WD; Brittinger WD; Deckert DW; Belz GG; Schubert I Arzneimittelforschung; 1978; 28(3a):562-5. PubMed ID: 580591 [TBL] [Abstract][Full Text] [Related]
4. [Meproscillarin, a new semisynthetic cardiac glycoside/chemistry and physical properties (author's transl)]. Kubinyi H Arzneimittelforschung; 1978; 28(3a):493-5. PubMed ID: 580577 [TBL] [Abstract][Full Text] [Related]
5. [Elimination of meproscillarin by hemoperfusion (author's transl)]. Rupp M; Brass H; Belz GG Arzneimittelforschung; 1978; 28(3a):567-9. PubMed ID: 580593 [TBL] [Abstract][Full Text] [Related]
6. [On the development of an oral preparation of meproscillarin (author's transl)]. Einig H; Mayer D Arzneimittelforschung; 1978; 28(3a):527-31. PubMed ID: 580583 [TBL] [Abstract][Full Text] [Related]
7. [Preliminary hemodynamic studies on the activity of meproscillarin (author's transl)]. Klein WW; Pavek P Arzneimittelforschung; 1978; 28(3a):553-5. PubMed ID: 580588 [TBL] [Abstract][Full Text] [Related]
8. [Labelling meproscillarin with tritium at the C-19 position (author's transl)]. Schenk G; Albrecht HP; Lietz H Arzneimittelforschung; 1978; 28(3a):518-9. PubMed ID: 580581 [TBL] [Abstract][Full Text] [Related]
9. [Long-term study with the novel cardiac glycoside meproscillarin (author's transl)]. Eckardt A; Koch W; Safer A Arzneimittelforschung; 1978; 28(3a):570-3. PubMed ID: 348206 [TBL] [Abstract][Full Text] [Related]
10. [The influence of meproscillarin on human left ventricular function (author's transl)]. Turina J; Krayenbühl HP Arzneimittelforschung; 1978; 28(3a):555-7. PubMed ID: 580589 [TBL] [Abstract][Full Text] [Related]
11. [Clinical study of meproscillarin rates of inactivation and persistence, bioavailability and maintenance dose]. Herken H; Brandes J Arzneimittelforschung; 1978; 28(3a):557-60. PubMed ID: 580590 [TBL] [Abstract][Full Text] [Related]
12. [Effect of meproscillarin on left ventricular hemodynamics (author's transl)]. Pachinger O; Probst P Arzneimittelforschung; 1978; 28(3a):550-2. PubMed ID: 580587 [TBL] [Abstract][Full Text] [Related]
13. [Elimination rate of meproscillarin following repeated application in patients with reduced renal function (author's transl)]. Beckmann H; Belz GG; Quellhorst E Arzneimittelforschung; 1978; 28(3a):565-7. PubMed ID: 580592 [TBL] [Abstract][Full Text] [Related]
14. [Clinical observations during accumulative oral glycoside therapy with meproscillarin (author's transl)]. Pozenel H Arzneimittelforschung; 1978; 28(3a):560-2. PubMed ID: 348205 [TBL] [Abstract][Full Text] [Related]
15. Metabolism of labetalol by animals and man. Martin LE; Hopkins R; Bland R Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152 [TBL] [Abstract][Full Text] [Related]
16. [Studies on the pharmacokinetics of meproscillarin (author's transl)]. Belz GG; Belz G Arzneimittelforschung; 1978; 28(3a):535-9. PubMed ID: 580584 [No Abstract] [Full Text] [Related]
17. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109 [TBL] [Abstract][Full Text] [Related]
18. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs. Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948 [TBL] [Abstract][Full Text] [Related]
19. Metabolism and disposition of diethylene glycol in rat and dog. Mathews JM; Parker MK; Matthews HB Drug Metab Dispos; 1991; 19(6):1066-70. PubMed ID: 1687012 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs. Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]